Skip to main content
FinSpry Logo
FinSpry
SYRE logo
SYRE
(NASDAQ)
Spyre Therapeutics, Inc.
$47.58-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Spyre Therapeutics (SYRE) Stock Price & Financial Analysis

Spyre Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$46.27 - $48.40
52-Week High$51.06
52-Week Low$10.91
Open$47.17
Volume438.01K
Average Volume (3M)438.01K
Market Cap16.46B
Shares Outstanding346.05M
Price to Sales (P/S)186.99
Price to Book (P/B)23.66
EV/EBITDA-74.85
Revenue (TTM)90.49M
Net Income (TTM)-155.20M
EPS (TTM)$-0.45
Profit Margin-171.51%
Operating Margin-242.63%
Return on Equity (ROE)-21.70%
Debt to Equity0.00
50-Day MA$39.37
200-Day MA$26.10
52-Week Change219.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Spyre Therapeutics

What is the current stock price for SYRE?

As of the latest trading session, SYRE stock trades at $47.58. The 52-week range is $10.91–$51.06, with a day range of $46.27–$48.40.

What is the P/E ratio for SYRE?

The P/E ratio (Price-to-Earnings) for SYRE is shown in the Key Statistics section. This valuation metric helps compare Spyre Therapeutics, Inc. to industry peers.

Does SYRE pay dividends?

Spyre Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SYRE?

Based on 3 analysts, the consensus for SYRE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SYRE?

Spyre Therapeutics's market capitalization is $16.46B, classifying it as a large-cap company. Spyre Therapeutics operates in the Healthcare sector within the Biotechnology industry.